[1]
Sontag SJ, The medical management of reflux esophagitis. Role of antacids and acid inhibition. Gastroenterology clinics of North America. 1990 Sep [PubMed PMID: 1977703]
[2]
El-Serag HB,Sweet S,Winchester CC,Dent J, Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun [PubMed PMID: 23853213]
[3]
Moayyedi P,Axon AT, Review article: gastro-oesophageal reflux disease--the extent of the problem. Alimentary pharmacology [PubMed PMID: 16042655]
[4]
Shaker R,Castell DO,Schoenfeld PS,Spechler SJ, Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. The American journal of gastroenterology. 2003 Jul [PubMed PMID: 12873567]
[5]
Eisen G, The epidemiology of gastroesophageal reflux disease: what we know and what we need to know. The American journal of gastroenterology. 2001 Aug [PubMed PMID: 11510763]
[6]
Maton PN,Burton ME, Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drugs. 1999 Jun [PubMed PMID: 10400401]
[7]
Weberg R,Berstad K,Berstad A, Acute effects of antacids on gastric juice components in duodenal ulcer patients. European journal of clinical investigation. 1990 Oct [PubMed PMID: 2124982]
[8]
Tarnawski A,Tanoue K,Santos AM,Sarfeh IJ, Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scandinavian journal of gastroenterology. Supplement. 1995 [PubMed PMID: 8578218]
[9]
Soll AH,Weinstein WM,Kurata J,McCarthy D, Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Annals of internal medicine. 1991 Feb 15 [PubMed PMID: 1987878]
[10]
Schucker JJ,Ward KE, Hyperphosphatemia and phosphate binders. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2005 Nov 15 [PubMed PMID: 16278327]
[11]
Rodriguez-Stanley S,Ahmed T,Zubaidi S,Riley S,Akbarali HI,Mellow MH,Miner PB, Calcium carbonate antacids alter esophageal motility in heartburn sufferers. Digestive diseases and sciences. 2004 Nov-Dec [PubMed PMID: 15628717]
[12]
Tarnawski A,Hollander D,Gergely H, Antacids: new perspectives in cytoprotection. Scandinavian journal of gastroenterology. Supplement. 1990 [PubMed PMID: 2205902]
[13]
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003 Oct [PubMed PMID: 14520607]
[14]
Chao HH,Guo CH,Huang CB,Chen PC,Li HC,Hsiung DY,Chou YK, Arsenic, cadmium, lead, and aluminium concentrations in human milk at early stages of lactation. Pediatrics and neonatology. 2014 Apr [PubMed PMID: 24231114]
[15]
Fanni D,Ambu R,Gerosa C,Nemolato S,Iacovidou N,Van Eyken P,Fanos V,Zaffanello M,Faa G, Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods. World journal of pediatrics : WJP. 2014 May [PubMed PMID: 24801228]
[16]
Mahadevan U,Kane S, American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul [PubMed PMID: 16831610]
[17]
Tsou VM,Young RM,Hart MH,Vanderhoof JA, Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991 Feb [PubMed PMID: 1987526]
[18]
Woodard-Knight L,Fudge A,Teubner J,Simmer K, Aluminium absorption and antacid therapy in infancy. Journal of paediatrics and child health. 1992 Jun [PubMed PMID: 1605980]
[20]
Robinson RF,Casavant MJ,Nahata MC,Mahan JD, Metabolic bone disease after chronic antacid administration in an infant. The Annals of pharmacotherapy. 2004 Feb [PubMed PMID: 14742764]
[21]
Pivnick EK,Kerr NC,Kaufman RA,Jones DP,Chesney RW, Rickets secondary to phosphate depletion. A sequela of antacid use in infancy. Clinical pediatrics. 1995 Feb [PubMed PMID: 7729110]